vs

Side-by-side financial comparison of General Enterprise Ventures, Inc. (CITR) and HCW Biologics Inc. (HCWB). Click either name above to swap in a different company.

HCW Biologics Inc. is the larger business by last-quarter revenue ($394.8K vs $288.2K, roughly 1.4× General Enterprise Ventures, Inc.). HCW Biologics Inc. runs the higher net margin — -854.4% vs -2751.2%, a 1896.8% gap on every dollar of revenue. On growth, General Enterprise Ventures, Inc. posted the faster year-over-year revenue change (169.3% vs -70.2%). General Enterprise Ventures, Inc. produced more free cash flow last quarter ($-1.5M vs $-2.9M). Over the past eight quarters, General Enterprise Ventures, Inc.'s revenue compounded faster (218.8% CAGR vs -45.8%).

The Hewlett Packard Enterprise Company (HPE) is an American multinational information technology company based in Spring, Texas. It is a business-focused organization which works in servers, storage, networking, containerization software and consulting and support. HPE was ranked No. 107 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.

HCW Biologics Inc. is a clinical-stage biotechnology company focused on researching and developing novel immunotherapies and biological products targeting unmet medical needs in oncology, chronic inflammatory disorders, and autoimmune diseases. It primarily operates in the U.S., advancing multiple pipeline candidates through early to mid-stage clinical trials.

CITR vs HCWB — Head-to-Head

Bigger by revenue
HCWB
HCWB
1.4× larger
HCWB
$394.8K
$288.2K
CITR
Growing faster (revenue YoY)
CITR
CITR
+239.4% gap
CITR
169.3%
-70.2%
HCWB
Higher net margin
HCWB
HCWB
1896.8% more per $
HCWB
-854.4%
-2751.2%
CITR
More free cash flow
CITR
CITR
$1.4M more FCF
CITR
$-1.5M
$-2.9M
HCWB
Faster 2-yr revenue CAGR
CITR
CITR
Annualised
CITR
218.8%
-45.8%
HCWB

Income Statement — Q3 FY2025 vs Q4 FY2024

Metric
CITR
CITR
HCWB
HCWB
Revenue
$288.2K
$394.8K
Net Profit
$-7.9M
$-3.4M
Gross Margin
-99.7%
20.0%
Operating Margin
-1470.3%
-795.9%
Net Margin
-2751.2%
-854.4%
Revenue YoY
169.3%
-70.2%
Net Profit YoY
-1110.1%
68.4%
EPS (diluted)
$-0.59
$-10.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CITR
CITR
HCWB
HCWB
Q3 25
$288.2K
Q2 25
$687.6K
Q1 25
$969.4K
Q4 24
$394.8K
Q3 24
$426.4K
Q2 24
$198.7K
$618.9K
Q1 24
$433.0K
$1.1M
Q4 23
$262.0K
$1.3M
Net Profit
CITR
CITR
HCWB
HCWB
Q3 25
$-7.9M
Q2 25
$-11.9M
Q1 25
$-10.9M
Q4 24
$-3.4M
Q3 24
$-3.9M
Q2 24
$-907.4K
$-15.3M
Q1 24
$-3.5M
$-7.5M
Q4 23
$-184.2K
$-10.7M
Gross Margin
CITR
CITR
HCWB
HCWB
Q3 25
-99.7%
Q2 25
46.0%
Q1 25
42.5%
Q4 24
20.0%
Q3 24
20.0%
Q2 24
48.6%
29.2%
Q1 24
79.2%
54.6%
Q4 23
71.4%
19.1%
Operating Margin
CITR
CITR
HCWB
HCWB
Q3 25
-1470.3%
Q2 25
-438.8%
Q1 25
-356.8%
Q4 24
-795.9%
Q3 24
-864.1%
Q2 24
-456.7%
-2445.8%
Q1 24
-608.9%
-665.1%
Q4 23
-69.6%
-813.3%
Net Margin
CITR
CITR
HCWB
HCWB
Q3 25
-2751.2%
Q2 25
-1731.1%
Q1 25
-1124.8%
Q4 24
-854.4%
Q3 24
-915.1%
Q2 24
-456.7%
-2469.1%
Q1 24
-812.8%
-662.8%
Q4 23
-70.3%
-806.7%
EPS (diluted)
CITR
CITR
HCWB
HCWB
Q3 25
$-0.59
Q2 25
$-0.19
Q1 25
$-0.23
Q4 24
$-10.47
Q3 24
$-4.13
Q2 24
$-0.02
$-16.16
Q1 24
$-0.04
$-0.20
Q4 23
$-0.01
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CITR
CITR
HCWB
HCWB
Cash + ST InvestmentsLiquidity on hand
$4.7M
Total DebtLower is stronger
$7.4M
Stockholders' EquityBook value
$8.5M
$-6.8M
Total Assets
$12.3M
$30.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CITR
CITR
HCWB
HCWB
Q3 25
Q2 25
Q1 25
Q4 24
$4.7M
Q3 24
$998.2K
Q2 24
$1.2M
Q1 24
$4.1M
Q4 23
$3.6M
Total Debt
CITR
CITR
HCWB
HCWB
Q3 25
Q2 25
Q1 25
Q4 24
$7.4M
Q3 24
$6.5M
Q2 24
$9.9M
Q1 24
$8.3M
Q4 23
$6.3M
Stockholders' Equity
CITR
CITR
HCWB
HCWB
Q3 25
$8.5M
Q2 25
$2.2M
Q1 25
$4.1M
Q4 24
$-6.8M
Q3 24
$-10.0M
Q2 24
$3.2M
$-6.3M
Q1 24
$3.8M
$8.7M
Q4 23
$13.5M
Total Assets
CITR
CITR
HCWB
HCWB
Q3 25
$12.3M
Q2 25
$8.7M
Q1 25
$9.1M
Q4 24
$30.2M
Q3 24
$26.6M
Q2 24
$5.4M
$26.8M
Q1 24
$5.3M
$30.4M
Q4 23
$5.3M
$28.5M
Debt / Equity
CITR
CITR
HCWB
HCWB
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.95×
Q4 23
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CITR
CITR
HCWB
HCWB
Operating Cash FlowLast quarter
$-1.5M
$-2.8M
Free Cash FlowOCF − Capex
$-1.5M
$-2.9M
FCF MarginFCF / Revenue
-525.6%
-746.8%
Capex IntensityCapex / Revenue
18.7%
28.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CITR
CITR
HCWB
HCWB
Q3 25
$-1.5M
Q2 25
$-1.2M
Q1 25
$-713.9K
Q4 24
$-2.8M
Q3 24
$-2.9M
Q2 24
$-424.9K
$-4.9M
Q1 24
$-343.7K
$-3.6M
Q4 23
$-391.8K
$-3.9M
Free Cash Flow
CITR
CITR
HCWB
HCWB
Q3 25
$-1.5M
Q2 25
$-1.4M
Q1 25
$-740.9K
Q4 24
$-2.9M
Q3 24
$-3.0M
Q2 24
$-4.9M
Q1 24
$-3.7M
Q4 23
$-7.6M
FCF Margin
CITR
CITR
HCWB
HCWB
Q3 25
-525.6%
Q2 25
-196.7%
Q1 25
-76.4%
Q4 24
-746.8%
Q3 24
-695.0%
Q2 24
-788.7%
Q1 24
-331.4%
Q4 23
-574.8%
Capex Intensity
CITR
CITR
HCWB
HCWB
Q3 25
18.7%
Q2 25
20.5%
Q1 25
2.8%
Q4 24
28.7%
Q3 24
8.7%
Q2 24
0.0%
3.0%
Q1 24
0.0%
11.5%
Q4 23
280.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons